Opposition · USPTO

Opposition 91220972

OtherUSPTO

Opposition 91220972 at USPTO between Blue Cross and Blue Shield Association and Augmedix, Inc., over the mark AUGMEDIX, filed Mar 9, 2015. Status in the office record: other.

Status
Other
Result
Other
Filed
Mar 9, 2015
Marks involved
11
Parties

Who is involved

The parties as named in the office record.

Opponent

Blue Cross and Blue Shield Association

Company trademarks
Respondent

Augmedix, Inc.

Timeline

How the case has moved

Dates from the USPTO record and the AUGMEDIX filing.

  1. AUGMEDIX filed

    Application 86084950 filed at the USPTO.
  2. Opposition filed

    Blue Cross and Blue Shield Association started opposition 91220972 at USPTO against AUGMEDIX.
Marks

Marks involved

1 contested mark, 10 marks the challenger relies on.

MarkRoleApplicationOffice
AUGMEDIXContested86084950USPTO
[Design mark]Relied on71531753USPTO
[Design mark]Relied on72442919USPTO
[Design mark]Relied on72450146USPTO
[Design mark]Relied on73555889USPTO
BLUE CROSSRelied on73555892USPTO
[Design mark]Relied on74187033USPTO
[Design mark]Relied on74268723USPTO
BLUEWEBRelied on75372093USPTO
BLUE WIZARDRelied on78139855USPTO
BLUERelied on85346475USPTO
API

Get this data via the API

Every fact on this page comes from the Signa API. Track oppositions and cancellations on any mark with one request.

  • GET/v1/proceedings/{id}

    Parties, dates, outcome and every mark in the case

  • GET/v1/proceedings?trademark_id={trademark_id}

    Every proceeding on a mark

GET /v1/proceedings/{id}
ID=prc_4f9d1431-6ab9-4a35-9bae-a8b686cc33aa
curl https://api.signa.so/v1/proceedings/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "prc_4f9d1431-6ab9-4a35-9bae-a8b686cc33aa",
  "object": "proceeding",
  "proceeding_type": "opposition",
  "proceeding_number": "91220972",
  "status": "other",
  "office_code": "US",
  "filed_date": "2015-03-09",
  "parties": [
    {
      "name": "Blue Cross and Blue Shield Association",
      "role": "opponent"
    },
    {
      "name": "Augmedix, Inc.",
      "role": "respondent"
    }
  ]
}